ARCHIVES

Phase III Nexavar Trial Fails Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 37 No. 8 | August 29, 2014

Download PDF Visit The Full Archive

Related Articles

ASCO to Present 2013 Special Awards at Annual Meeting

May 31, 2013

In Brief: Chance for Rauscher Pay Increase Bill Seems Diminishing, But Schmidt Remains Confident

April 30, 1976

Mammography Hazard In ACS-NCI Screening Charged

October 17, 1975

Wanted: Methods To Measure Or Estimate Renal Function For Dosing Cancer Drugs

October 15, 2010

New Mexico, Michigan Win Saturation Implementation Contracts

June 6, 1975

Scientific Program Organized For XIIIth Cancer Congress

October 2, 1981